Charles Sternberg, Associate Editor05.03.22
BioIntelliSense, a continuous health monitoring and clinical intelligence company, has announced two new hospital partnerships—with UC Davis Health and Houston Methodist—focused on advancing remote care to address workforce shortages and create a more equitable, accessible and affordable patient care experience.
At the center of this strategic collaboration is a committed virtual care strategy that includes the deployment of BioIntelliSense’s data-driven clinical intelligence platform, to create a new standard of remote care, that reduces the cost and burden of traditional methods of vital sign collection.
“Remote care represents a safe and effective way for many people, especially in rural and low-income communities, to access necessary health care services in more convenient ways. As one of the nation’s leaders in telehealth, we’ve seen how real-time technology connects expertise with need, closing large time-lapse gaps in health care delivery,” said David Lubarsky, CEO of UC Davis Health. “Now, with continuous and simultaneous Internet connectivity enabling even more remote care, we can have hospital-level monitoring of multiple vital signs wherever patients are in-hospital, traveling, or at home.”
As a leading academic medical center with a patient-centered focus on digital transformation, UC Davis Health is poised to rapidly advance remote care initiatives with BioIntelliSense that combine an effortless user experience with medical grade clinical accuracy.
The introduction of BioIntelliSense’s medical grade continuous data and smart alerting technology within the in-patient setting, beyond the Intensive Care Unit, provides clinicians a unique opportunity to gain a high-resolution view of a patient’s health status. The passive collection of continuous multi-parameter data and sophisticated algorithms enables better recognition of hemodynamic stability that can lead to earlier hospital discharge, resulting in increased patient satisfaction and savings.
The benefits of this continuous care model extend beyond the hospital to the home by providing a scalable platform for monitoring vital signs, symptoms, and physiologic biometrics for earlier detection of adverse trends without the cost and complexity of traditional RPM.
“We formed CoLab at UC Davis Health to support open innovation with industry, pharma and payers by co-designing, co-validating and co-transforming breakthrough technologies in digital health, devices and AI,” said Ashish Atreja, CIO and chief digital health officer at UC Davis Health. “We are thrilled about partnership with BioIntelliSense that supports our strategic goal of delivering high acuity care at home that is grounded in equity so no patient gets left behind.”
In the coming months, UC Davis Health and BioIntelliSense will bring together their brightest minds and best resources to co-validate continuous care models and iteratively learn how best to deliver an exceptional patient and clinical experience while prioritizing patient safety and efficacy at scale. And in the process, they’ll expand access to BioIntelliSense’s remote care solution to create a more equitable, accessible and affordable continuous monitoring experience across patient populations and care settings.
“We are proud to embark on this strategic collaboration with UC Davis Health to advance remote care for patients across the care continuum,” said James Mault, MD, founder and CEO of BioIntelliSense. “With cost effective, data-driven continuous care, we can bend the cost curve and extend the reach of advanced remote care technologies to improve how we treat and care for patients with complex conditions including oncology, orthopedics, cardiac, infectious disease and renal disease.”
“This new strategic collaboration with BioIntelliSense exemplifies Houston Methodist’s continued commitment to advancing world-class expertise and greater efficiency to deliver the highest quality and most impactful care,” said Dr. Sarah Pletcher, vice president and executive medical director, Strategic Innovation, Houston Methodist. “This collaboration keeps the patient at the center as we continue to maximize our leadership in healthcare innovation.”
The collaboration will also address the rising costs and burdens of the growing healthcare workforce shortage. BioIntelliSense and Houston Methodist will jointly design and develop a state-of-the-art virtual care control center at Houston Methodist to enable seamless, scalable, continuous monitoring of patients across in-hospital to home care settings.
“Data-driven remote patient monitoring that is simple, clinically accurate, and cost-effective, is the future of healthcare delivery,” said James Mault, MD, founder and CEO of BioIntelliSense. “We are proud to work alongside our partners at Houston Methodist to pioneer a continuous care model that provides actionable data and clinical intelligence to enable our overburdened healthcare workforce take better care of patients in any care setting.”
The MOU further establishes the use of leading biosensor technology and the development of advanced algorithms, care models, and data analytics for monitoring and treating a range of complex conditions spanning heart and vascular, orthopedics, oncology, infectious diseases, transplants, and others.
Anelto’s RemoteCareLive! Suite of RPM solutions is designed specifically for seniors, collecting vital signs, conducting telehealth visits with a physician, and delivering healthy lifestyle tips—all from a purpose-built healthcare console.
RemoteCareLive! makes it simple for patients to set up and easily take their own vital signs, including blood pressure, weight, pulse oximetry, and now continuous vital sign and biometric data effortlessly with BioIntelliSense. Health care professionals can monitor this data in near real-time and longitudinally to spot trends that need immediate action or further monitoring. Integration with BioIntelliSense allows high-frequency patient trending data and alerting to be collected through the flagship BioSticker and award-winning BioButton wearable medical devices for patients who benefit most from continuous passive monitoring.
“BioIntelliSense is proud of its collaboration with Anelto in creating an effortless user experience for senior monitoring within facilities and home settings,” commented James Mault. “Our integration with the RemoteCareLive! platform provides a comprehensive solution that leverages BioIntelliSense’s clinically validated and continuous trending data, along with algorithmic-based alerting, to provide scalable peace-of-mind remote monitoring for vulnerable senior patient populations.”
Strategic Collaboration with UC Davis Health
California-based UC Davis Health and BioIntelliSense have entered a strategic collaboration that advances remote patient monitoring (RPM) across care settings using the FDA-cleared BioIntelliSense wearable technology and algorithmic-based BioCloud data analytics.At the center of this strategic collaboration is a committed virtual care strategy that includes the deployment of BioIntelliSense’s data-driven clinical intelligence platform, to create a new standard of remote care, that reduces the cost and burden of traditional methods of vital sign collection.
“Remote care represents a safe and effective way for many people, especially in rural and low-income communities, to access necessary health care services in more convenient ways. As one of the nation’s leaders in telehealth, we’ve seen how real-time technology connects expertise with need, closing large time-lapse gaps in health care delivery,” said David Lubarsky, CEO of UC Davis Health. “Now, with continuous and simultaneous Internet connectivity enabling even more remote care, we can have hospital-level monitoring of multiple vital signs wherever patients are in-hospital, traveling, or at home.”
As a leading academic medical center with a patient-centered focus on digital transformation, UC Davis Health is poised to rapidly advance remote care initiatives with BioIntelliSense that combine an effortless user experience with medical grade clinical accuracy.
The introduction of BioIntelliSense’s medical grade continuous data and smart alerting technology within the in-patient setting, beyond the Intensive Care Unit, provides clinicians a unique opportunity to gain a high-resolution view of a patient’s health status. The passive collection of continuous multi-parameter data and sophisticated algorithms enables better recognition of hemodynamic stability that can lead to earlier hospital discharge, resulting in increased patient satisfaction and savings.
The benefits of this continuous care model extend beyond the hospital to the home by providing a scalable platform for monitoring vital signs, symptoms, and physiologic biometrics for earlier detection of adverse trends without the cost and complexity of traditional RPM.
“We formed CoLab at UC Davis Health to support open innovation with industry, pharma and payers by co-designing, co-validating and co-transforming breakthrough technologies in digital health, devices and AI,” said Ashish Atreja, CIO and chief digital health officer at UC Davis Health. “We are thrilled about partnership with BioIntelliSense that supports our strategic goal of delivering high acuity care at home that is grounded in equity so no patient gets left behind.”
In the coming months, UC Davis Health and BioIntelliSense will bring together their brightest minds and best resources to co-validate continuous care models and iteratively learn how best to deliver an exceptional patient and clinical experience while prioritizing patient safety and efficacy at scale. And in the process, they’ll expand access to BioIntelliSense’s remote care solution to create a more equitable, accessible and affordable continuous monitoring experience across patient populations and care settings.
“We are proud to embark on this strategic collaboration with UC Davis Health to advance remote care for patients across the care continuum,” said James Mault, MD, founder and CEO of BioIntelliSense. “With cost effective, data-driven continuous care, we can bend the cost curve and extend the reach of advanced remote care technologies to improve how we treat and care for patients with complex conditions including oncology, orthopedics, cardiac, infectious disease and renal disease.”
Strategic Collaboration with Houston Methodist
BioIntelliSense also entered a new collaboration with Houston Methodist to advance cutting-edge remote monitoring and analytics technologies across the healthcare continuum, from in-hospital to at-home. The recently executed Memorandum of Understanding (MOU) identifies several areas of strategic focus for improving patient care, increasing clinical workflow efficiencies, and reducing the burden on healthcare systems.“This new strategic collaboration with BioIntelliSense exemplifies Houston Methodist’s continued commitment to advancing world-class expertise and greater efficiency to deliver the highest quality and most impactful care,” said Dr. Sarah Pletcher, vice president and executive medical director, Strategic Innovation, Houston Methodist. “This collaboration keeps the patient at the center as we continue to maximize our leadership in healthcare innovation.”
The collaboration will also address the rising costs and burdens of the growing healthcare workforce shortage. BioIntelliSense and Houston Methodist will jointly design and develop a state-of-the-art virtual care control center at Houston Methodist to enable seamless, scalable, continuous monitoring of patients across in-hospital to home care settings.
“Data-driven remote patient monitoring that is simple, clinically accurate, and cost-effective, is the future of healthcare delivery,” said James Mault, MD, founder and CEO of BioIntelliSense. “We are proud to work alongside our partners at Houston Methodist to pioneer a continuous care model that provides actionable data and clinical intelligence to enable our overburdened healthcare workforce take better care of patients in any care setting.”
The MOU further establishes the use of leading biosensor technology and the development of advanced algorithms, care models, and data analytics for monitoring and treating a range of complex conditions spanning heart and vascular, orthopedics, oncology, infectious diseases, transplants, and others.
Channel Partnership with Anelto
These two announcements come on the heels of the channel partnership announced recently with Anelto, a leader in Remote Patient Monitoring (RPM) solutions. The collaboration strengthens Anelto’s proven leadership in delivering patient-centric, feature-rich healthcare solutions to provide better experiences and outcomes for seniors with complex or chronic care management needs.Anelto’s RemoteCareLive! Suite of RPM solutions is designed specifically for seniors, collecting vital signs, conducting telehealth visits with a physician, and delivering healthy lifestyle tips—all from a purpose-built healthcare console.
RemoteCareLive! makes it simple for patients to set up and easily take their own vital signs, including blood pressure, weight, pulse oximetry, and now continuous vital sign and biometric data effortlessly with BioIntelliSense. Health care professionals can monitor this data in near real-time and longitudinally to spot trends that need immediate action or further monitoring. Integration with BioIntelliSense allows high-frequency patient trending data and alerting to be collected through the flagship BioSticker and award-winning BioButton wearable medical devices for patients who benefit most from continuous passive monitoring.
“BioIntelliSense is proud of its collaboration with Anelto in creating an effortless user experience for senior monitoring within facilities and home settings,” commented James Mault. “Our integration with the RemoteCareLive! platform provides a comprehensive solution that leverages BioIntelliSense’s clinically validated and continuous trending data, along with algorithmic-based alerting, to provide scalable peace-of-mind remote monitoring for vulnerable senior patient populations.”
